๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The basis for current treatment recommendations for malignant gliomas

โœ Scribed by Howard A. Fine

Publisher
Springer US
Year
1994
Tongue
English
Weight
977 KB
Volume
20
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Intra-arterial cisplatin for the treatme
Intra-arterial cisplatin for the treatment of malignant gliomas
โœ Herbert B. Newton; Michaelyn A. Page; Larry Junck; Harry S. Greenberg ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer US ๐ŸŒ English โš– 571 KB

Cisplatin (DDP) is a chemotherapeutic agent that has shown efficacy against primary CNS malignancies. Intraarterial (IA) administration of DDP to patients with brain tumors should produce higher peak levels of drug than intravenous (IV) administration of an identical dose and reduce systemic toxicit

Novel Treatment Strategies for Malignant
Novel Treatment Strategies for Malignant Gliomas Using Neural Stem Cells
โœ Michael C. Oh; Daniel A. Lim ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 523 KB

Recent studies in stem cell biology have refined our understanding of the origin and progression of cancer. Identification and characterization of endogenous neural stem cells (NSCs), especially those in the adult human brain, have inspired new ideas for selectively targeting and destroying malignan

Implantable polymers for tirapazamine tr
Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma
โœ Xuan Yuan; Kevin Tabassi; Jeffery A. Williams ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 240 KB ๐Ÿ‘ 1 views

Malignant gliomas remain refractory to intensive radiotherapy and cellular hypoxia enhances clinical radioresistance. Under hypoxic conditions, the benzotriazine di-N-oxide (3-amino-1,2,4-benzotriazine 1,4-dioxide) (tirapazamine) is reduced to yield a free-radical intermediate that results in DNA da